Search Results

Keywords: "United Kingdom"

First medical cannabis clinic in United Kingdom opens

Britain’s first dedicated medical marijuana clinic opened in Manchester, setting the groundwork for wider use of MMJ in the country and sparking criticism from some quarters of the medical community. More clinics are expected to open in London and Birmingham later this spring, according to a news release. Only a handful of patients have had access […]

Read More

United Kingdom sets date for first medical cannabis prescriptions

Specially trained doctors will be able to legally issue prescriptions for cannabis-based medicines for the first time in the United Kingdom starting Nov. 1, marking an important milestone for the medical marijuana industry in the country. The law introduced in the U.K. Parliament on Thursday will ultimately pave the way for one of the largest […]

Read More

Cannabis extractors are exploring THC remediation options

One is quick but expensive. The other is economical but slow – and tricky to get just right. Extractors looking to isolate certain cannabinoids have long relied on chromatography to dial up or down the many cannabinoids in marijuana and hemp plants. But a technique formerly derided as the mark of an inferior product – […]

Read More

Curaleaf enters European cannabis market with $286 million acquisition of Emmac Life Sciences

Curaleaf Holdings said Tuesday it signed a $286 million definitive agreement to acquire London-based medical marijuana company Emmac Life Sciences, giving the Massachusetts-based multistate operator a major foothold in the European cannabis market and a leg up on rival businesses. The terms of the deal call for Curaleaf to pay $286 million up front, with […]

Read More

Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting, only businesses that have marketable intellectual property and an established foothold in the medical cannabinoid arena will draw serious […]

Read More

France chooses companies to supply free medical cannabis for trial program

The French Agency for the Safety of Medicines and Health Products (ANSM) selected the companies that will supply France’s medical cannabis pilot program that’s intended to provide free products to patients enrolled in the trial. Cannabis companies from Australia, Canada, Israel and the United Kingdom – in partnership with French pharmaceutical distributors – will provide […]

Read More

GW Pharma expects fiscal 2020 sales to reach $526 million

United Kingdom-based GW Pharmaceuticals expects to report annual sales of roughly $526 million for the year ended Dec. 31, 2020, the company said in a preview of its fourth-quarter and full-year results. Fourth-quarter net sales will be approximately $148 million, based on preliminary unaudited financial information, GW said. Epidiolex, the company’s most successful product, accounts […]

Read More

Cannabis firm Canopy Growth sues GW Pharma, claiming patent infringement

Canadian cannabis producer Canopy Growth Corp. is suing Britain’s GW Pharmaceuticals in U.S. federal court, alleging that GW is knowingly infringing upon Canopy’s intellectual property. GW uses a Canopy-patented method to extract the CBD that’s the active ingredient in its Epidiolex medication, according to a complaint filed Tuesday in the U.S. District Court for the Western […]

Read More

European cannabis producer raises $20 million

Emmac Life Sciences, a European vertically integrated cannabis producer, said it raised 15 million pounds ($20 million) via an issue of convertible loan notes. The Dec. 16 issue “saw strong support from existing shareholders, with Measure 8 Venture Partners, Emmac’s largest existing cash investor, leading the round with a significant investment,” according to a news […]

Read More